Literature DB >> 15917577

Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin.

Shannon D Putnam1, John W Sanders, David R Tribble, David R Rockabrand, Mark S Riddle, Patrick J Rozmajzl, Robert W Frenck.   

Abstract

Changes in antimicrobial resistance of Escherichia coli among deployed U.S. military personnel being treated for diarrhea were evaluated. Stool samples were collected pretreatment and on days 7, 14, and 28 posttreatment. Resistance to ciprofloxacin was noted in 13.3% of baseline specimens, and rates of resistance against multiple antibiotics increased dramatically from baseline to day 7 and then tapered off to return to pretreatment levels by day 28, except for ciprofloxacin, suggesting that population accumulative usage of fluoroquinolones may result in an incremental increase in resistance rates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917577      PMCID: PMC1140542          DOI: 10.1128/AAC.49.6.2571-2572.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Riddle of biofilm resistance.

Authors:  K Lewis
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes.

Authors:  L V Friedrich; R L White; J A Bosso
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

3.  Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora.

Authors:  P Richard; M H Delangle; F Raffi; E Espaze; H Richet
Journal:  Clin Infect Dis       Date:  2000-12-11       Impact factor: 9.079

4.  An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection.

Authors:  J W Sanders; D W Isenbarger; S E Walz; L W Pang; D A Scott; C Tamminga; B A Oyofo; W C Hewitson; J L Sanchez; C Pitarangsi; P Echeverria; D R Tribble
Journal:  Am J Trop Med Hyg       Date:  2002-11       Impact factor: 2.345

5.  Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.

Authors:  J N Anderl; M J Franklin; P S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.

Authors:  M Tayfour; A Yuce; N Yulug
Journal:  Saudi Med J       Date:  2001-10       Impact factor: 1.484

Review 8.  Empirical antimicrobial therapy for traveler's diarrhea.

Authors:  J A Adachi; L Ostrosky-Zeichner; H L DuPont; C D Ericsson
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

9.  Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

Authors:  Melinda M Neuhauser; Robert A Weinstein; Robert Rydman; Larry H Danziger; George Karam; John P Quinn
Journal:  JAMA       Date:  2003-02-19       Impact factor: 56.272

10.  Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.

Authors:  D F Sahm; I A Critchley; L J Kelly; J A Karlowsky; D C Mayfield; C Thornsberry; Y R Mauriz; J Kahn
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

View more
  1 in total

1.  Efficacy of ciprofloxacin in an experimental model of Escherichia coli chorioamnionitis in rabbits.

Authors:  Elise Launay; Nicolas Joram; Cédric Jacqueline; Anne Francoise Miegeville; Jocelyne Caillon; Gilles Potel; Jean Christophe Roze; Christèle Gras-Le Guen
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.